Pulmonary embolism arrhythmia

Cardiopulmonary arrest in adults usually results from arrhythmias. The most common arrhythmias are ventricular fibrillation (VF) and pulseless ventricular tachycardia (PVT), often in patients after myocardial infarction (MI) or pulmonary embolism (PE). In children, cardiopulmonary arrest is often the terminal event of progressive shock or respiratory failure. 

Vascular disease, MI, angina pectoris, atrial fibrillation, heart failure, arrhythmia, atrial arrhythmia, and pulmonary embolism have been reported. 

Niacin in the CDP significantly reduced definite, nonfatal MI as compared with placebo (10.1% versus 13.9%), whereas clofibrate did not reduce death from any cause or nonfatal or fatal MI at the 5-year follow-up period. Clofibrate did increase the rate of definite or suspected fatal or nonfatal pulmonary embolism or thrombophlebitis compared with placebo (5.8% versus 3.6%) after adjusting for baseline characteristics for total follow-up. Other findings with clofibrate that occurred more frequently than with placebo included intermittent claudication, arrhythmias, palpable spleen, cholelithiasis (including cholecystectomy), and more frequent use of anticoagulants. Skin reactions, gastrointestinal complaints, and the use of gout... 

---